Next Article in Journal
Differences in Penile Hemodynamic Profiles in Patients with Erectile Dysfunction and Anxiety
Next Article in Special Issue
Optimal Allocation of the Limited COVID-19 Vaccine Supply in South Korea
Previous Article in Journal
Perioperative Individualized Goal Directed Therapy for Cardiac Surgery: A Historical-Prospective, Comparative Effectiveness Study
Previous Article in Special Issue
Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?—The IDENTIFY Trial
Article

“Go To Travel” Campaign and Travel-Associated Coronavirus Disease 2019 Cases: A Descriptive Analysis, July–August 2020

Kyoto University School of Public Health, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2021, 10(3), 398; https://doi.org/10.3390/jcm10030398
Received: 1 December 2020 / Revised: 13 January 2021 / Accepted: 19 January 2021 / Published: 21 January 2021
The Japanese government initiated the Go To Travel campaign on 22 July 2020, offering deep discounts on hotel charges and issuing coupons to be used for any consumption at travel destinations in Japan. In the present study, we aimed to describe the possible epidemiological impact of the tourism campaign on increasing travel-associated cases of coronavirus disease 2019 (COVID-19) in the country. We compared the incidence rates of travel-associated and tourism-related cases prior to and during the campaign. The incidence of travel-associated COVID-19 cases during the tourism campaign was approximately three times greater than the control period 22 June to 21 July 2020 and approximately 1.5 times greater than the control period of 15 to 19 July. The incidence owing to tourism was approximately 8 times and 2–3 times greater than the control periods of 22 June to 21 July and 15 to 19 July, respectively. Although the second epidemic wave in Japan had begun to decline by mid-August, enhanced domestic tourism may have contributed to increasing travel-associated COVID-19 cases during 22 to 26 July, the early stage of the Go To Travel campaign. View Full-Text
Keywords: tourism; sightseeing; epidemiology; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); coronavirus disease 2019 (COVID-19); mobility tourism; sightseeing; epidemiology; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); coronavirus disease 2019 (COVID-19); mobility
Show Figures

Figure 1

MDPI and ACS Style

Anzai, A.; Nishiura, H. “Go To Travel” Campaign and Travel-Associated Coronavirus Disease 2019 Cases: A Descriptive Analysis, July–August 2020. J. Clin. Med. 2021, 10, 398. https://doi.org/10.3390/jcm10030398

AMA Style

Anzai A, Nishiura H. “Go To Travel” Campaign and Travel-Associated Coronavirus Disease 2019 Cases: A Descriptive Analysis, July–August 2020. Journal of Clinical Medicine. 2021; 10(3):398. https://doi.org/10.3390/jcm10030398

Chicago/Turabian Style

Anzai, Asami, and Hiroshi Nishiura. 2021. "“Go To Travel” Campaign and Travel-Associated Coronavirus Disease 2019 Cases: A Descriptive Analysis, July–August 2020" Journal of Clinical Medicine 10, no. 3: 398. https://doi.org/10.3390/jcm10030398

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop